Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116844
Status:
COMPLETED
Last Update Posted:
2018-02-12
First Post:
2005-06-30
Brief Title:
VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 HSV-2 Seropositive Subjects VALTREX Tablet is a Trademark of GlaxoSmithKline Group of Companies
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
VLX103596
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None